Relation between microRNA‐155 and inflammatory mediators in multiple sclerosis

Abstract

Multiple sclerosis (MS) is a complex autoimmune condition affecting the central nervous system characterized by axonal damage, demyelination, and chronic inflammation. Multiple molecular and cellular components mediate neuroinflammation in MS. In human macrophages and microglia, miRNA‐155 is an essential proinflammatory noncoding RNA that regulates phenotypic and functional polarization properties. This study was conducted to detect the plasma level of miRNA‐155 in RRMS and assess its relationship with inflammatory and anti‐inflammatory mediators. The study included 60 MS patients and 30 healthy controls. Real‐time quantitative polymerase chain reaction was utilized to detect miRNA‐155, iNOS, and SMAD2, whereas ELISA was used to determine TNF‐α, IFN‐ɣ, TGF‐β, and IL‐10 levels. There was no significant difference in miRNA‐155, SMAD2, and iNOS expression in MS patients compared to control subjects. In addition, there was a statistically significant increase in TNF‐α, INF‐ɣ, and TGF‐β levels. IL‐10 levels did not differ significantly between MS patients and healthy controls. There was a positive correlation between miRNA‐155 and TNF‐α (p < 0.000, r = 0.922), INF‐ɣ (p < 0.000, r = 0.81), and iNOS (p < 0.000, r = 0.916) and inverse correlation between miRNA‐155 and IL‐10 (p < 0.000, r = −0.928), TGF‐β (p < 0.000, r = −0.904) and SMAD2 (p < 0.000, r = −0.848). We conclude that expression of miRNA‐155 in MS may modulate macrophage/microglia polarization by increasing the secretion of TNF‐α, IFN‐ɣ & iNOS and decreasing anti‐inflammatory mediators IL10 and TGF‐β.